"With all of these relatively rare reports, the challenge for the clinicians and patients involved is to figure out is this really a result of a medication or is it an interaction of a variety of different factors," Dr
Public trial records describe studies evaluating LY3437943 in obesity, overweight, and related metabolic conditions
00:08:22 Vickie Danaher So I anticipate hearing more about orforglipron for this use, as well as other things its being studied for, including cardiovascular risk reduction and osteoarthritis
The true risk could be barely above baseline or it could be substantially elevated, the data simply cannot pin it down with precision
They're marketed as a convenient alternative to "pills, powders and needles" pop one on your arm in the morning, get on with your day, and supposedly the active ingredients are absorbed through your skin